Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidedness
Condition(s) studied
Investigational drug(s) / intervention(s)
anatomical liver resection: Based upon the segmental anatomy of the liver according to Couinaud system, anatomical resection (AR) was defined as resection of 1 or more complete hepatic segments in our study, including bisegmentectomy, right hemihepatectomy, left hemihepatectomy, extended right hemihepatectomy, extended left hemihepatectomy, single segmentectomy, caudate lobectomy, or a combination of these.
nonanatomical liver resection: Nonanatomical resection(NAR), known as wedge resection, was defined as resection of the tumor with a margin of normal parenchyma without regard to hepatic anatomy.
Study summary
In this study, colorectal cancer patients with initially resectable liver-only metastases, as prospectively confirmed by a local multidisciplinary team (MDT) according to predefined criteria, will be tested for RAS and BRAF tumor mutation status. Patients with gene mutant or right-sidedness will be randomised between anatomical resection (AR) or nonanatomical resection (NAR). The primary end-point is the relapse-free survival.
Eligibility
Primary outcome measure(s)
- relapse-free survival — 3 years
The relapse-free survival (PFS) was defined as the period from the start of initial liver resection to the date of tumor relapse or death
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zhongshan hospital | Shanghai | Shanghai Municipality |
More Fudan University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05881746 on ClinicalTrials.gov ↗ ← All trials in China